SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Journal of Psychopharmacology
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
0269881108089820v1
23/4/451    most recent
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Wann, B.
Right arrow Articles by Rousseau, G
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wann, B.
Right arrow Articles by Rousseau, G
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

research-article

Behavioural signs of depression and apoptosis in the limbic system following myocardial infarction: effects of sertraline

BP Wann

Centre de recherche, Hôpital Sacré-Cœur de Montréal, Montréal, Canada

TM Bah

Centre de recherche, Hôpital Sacré-Cœur de Montréal, Montréal, Canada

S Kaloustian

Centre de recherche, Hôpital Sacré-Cœur de Montréal, Montréal, Canada; Department of Pharmacology, Université de Montréal, Montréal, Canada

M Boucher

Centre de recherche, Hôpital Sacré-Cœur de Montréal, Montréal, Canada; Department of Pharmacology, Université de Montréal, Montréal, Canada

AM Dufort

Centre de recherche, Hôpital Sacré-Cœur de Montréal, Montréal, Canada

N Le Marec

Centre de recherche, Hôpital Sacré-Cœur de Montréal, Montréal, Canada; Department of Psychiatry, Université de Montréal, Montréal, Canada

R Godbout

Centre de recherche, Hôpital Sacré-Cœur de Montréal, Montréal, Canada; Department of Psychiatry, Université de Montréal, Montréal, Canada

G Rousseau

Centre de recherche, Hôpital Sacré-Cœur de Montréal, Montréal, Canada; Department of Pharmacology, Université de Montréal, Montréal, Canada

Abstract

Depression is diagnosed in 15–30% of patients following myocardial infarction (MI) and this may also be observed in the rat. We measured the effects of the antidepressant sertraline on behavioural and biochemical events following MI in a rat model. Following surgery, MI rats and sham controls were treated with sertraline (10 mg/kg, i.p.) or saline. Subgroups of rats were tested for behavioural depression 14 days after surgery. Apoptosis was estimated in other rats by measuring caspase-3 activity and TUNEL positive cells (3 days after surgery) in limbic structures (amygdale, hippocampus, hypothalamus, frontal and prefrontal cortices). Bax/Bcl-2 ratio was measured 14 days after surgery. Behavioural signs of depression (decreased sucrose intake and forced swimming time) were found in saline-treated MI rats but not in sertraline-treated rats. Compared with controls, caspase-3 activity and TUNEL positive cells were significantly increased in most limbic structures of MI rats. High prefrontal Bax/Bcl-2 ratio in MI rats correlated with low forced swimming time. Apoptosis was not found in sertraline-treated MI rats. These results establish the bases of a rat model of depression following MI and show for the first time that a selective serotonin reuptake inhibitor prevents both behavioural and biochemical markers in this model.

Key Words: anhedonia • apoptosis • behavioural despair • depression model • serotonin uptake

This version was published on June 1, 2009

Journal of Psychopharmacology, Vol. 23, No. 4, 451-459 (2009)
DOI: 10.1177/0269881108089820


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




Advertisement